| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Changing standards of care
|
Schwartzberg, Lee S.
|
|
2007
|
4 |
9 |
p. 517-
1 p.
|
artikel
|
| 2 |
Chemotherapeutics and cardiac toxicity: treatment considerations and management strategies
|
Safra, Tamar
|
|
2007
|
4 |
9 |
p. 540-548
9 p.
|
artikel
|
| 3 |
CMS restricts use of ESAs in cancer patients
|
Okon, Ted
|
|
2007
|
4 |
9 |
p. 565-
1 p.
|
artikel
|
| 4 |
Complete remission of metastatic Ewing's sarcoma/primitive neuroectodermal tumor with standard chemotherapy
|
Jasani, Nikesh
|
|
2007
|
4 |
9 |
p. 567-568
2 p.
|
artikel
|
| 5 |
Depression in the patient with brain cancer
|
Pangilinan Jr, Percival H.
|
|
2007
|
4 |
9 |
p. 533-537
5 p.
|
artikel
|
| 6 |
Electronic medical records and standardized data could mean a boost in clinical trials enrollment
|
Bongiorno, Natalie
|
|
2007
|
4 |
9 |
p. 557-558
2 p.
|
artikel
|
| 7 |
Healthcare and clinical research: a critical link through standards
|
Kush, Rebecca Daniels
|
|
2007
|
4 |
9 |
p. 553-557
5 p.
|
artikel
|
| 8 |
Liposomal doxorubicin extravasation
|
Held-Warmkessel, Jeanne
|
|
2007
|
4 |
9 |
p. 527-
1 p.
|
artikel
|
| 9 |
Liposomal doxorubicin extravasation
|
Laufman, Leslie R.
|
|
2007
|
4 |
9 |
p. 527-
1 p.
|
artikel
|
| 10 |
Liver-directed therapies for hepatocellular cancer
|
Choi, Minsig
|
|
2007
|
4 |
9 |
p. 571-575
5 p.
|
artikel
|
| 11 |
Lymphoid malignancies: a previously unrecognized risk factor for bone loss
|
Laufman, Leslie R.
|
|
2007
|
4 |
9 |
p. 561-563
3 p.
|
artikel
|
| 12 |
Sorafenib in advanced HCC
|
Abraham, Jame
|
|
2007
|
4 |
9 |
p. 528-529
2 p.
|
artikel
|
| 13 |
Sorafenib: new reference standard for systemic treatment of advanced hepatocellular carcinoma
|
Lau, Yiu-Keung
|
|
2007
|
4 |
9 |
p. 529-530
2 p.
|
artikel
|
| 14 |
The financial and economic concerns
|
Policicchio, Patricia A.
|
|
2007
|
4 |
9 |
p. 530-
1 p.
|
artikel
|
Tijdschrift beschrijving